EODData

FRA, 1OT: Ovid Therapeutics Inc

07 Oct 2026
LAST:

2.100

CHANGE:
 0.00
OPEN:
2.060
HIGH:
2.100
ASK:
0.000
VOLUME:
0
CHG(%):
0.00
PREV:
2.100
LOW:
2.060
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
07 Oct 262.0602.1002.0602.1000
06 Oct 262.1202.1202.1002.1000
05 Oct 262.0802.0802.0802.0800
02 Oct 262.1202.1202.0602.0600
01 Oct 262.1602.1802.1602.1800
30 Sep 262.2002.2002.2002.2000
29 Sep 262.1202.1202.1202.1200
28 Sep 262.0602.0602.0602.0600
25 Sep 262.1602.1602.0802.0800
24 Sep 262.2002.2002.1402.1400

PROFILE

Name:Ovid Therapeutics Inc
About:Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Sector:Healthcare
Industry:Biotechnology
Address:441 Ninth Avenue, New York, NY, United States, 10001
Website:https://www.ovidrx.com
ISIN:US6904691010
LEI:549300H36NUI4L6U8F17

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-10.00 
Forward P/E:-2.77 
PEG Ratio:0.70 
Price to Sales:283.76 
Price to Book:2.36 
Operating Margin:-21.01 
Return on Assets:-0.23 
Return on Equity:-0.26 
Revenue:1.35M 
Shares:71.11M 
Market Cap:149.33M 

TECHNICAL INDICATORS

MA5:2.100.2%
MA10:2.110.6%
MA20:2.205.0%
MA50:2.236.2%
MA100:2.183.7%
MA200:1.919.7%
STO9:28.57
STO14:10.53 
RSI14:37.21 
WPR14:-89.47 
MTM14:-0.20
ROC14:-0.09 
ATR:0.07 
Week High:2.204.8%
Week Low:2.061.9%
Month High:2.4416.2%
Month Low:2.069.7%
Year High:2.5220.0%
Year Low:1.02105.9%
Volatility:51.68